Amgen Inc. Profile Avatar - Palmy Investing

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…

Drug Manufacturers - General
US, Thousand Oaks [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
Graham Jonathan P
EVP & Gen. Counsel & Secy.
12/06/24 [Form 4]
Khosla Rachna
SVP, Business Development
11/06/24 [Form 4]
Busch Matthew C.
VP, Finance & CAO
11/06/24 [Form 4]
Grygiel Nancy A.
SVP & CCO
07/31/24 [Form 4]
Santos Esteban
EVP, Operations
05/09/24 [Form 4]
Reese David M
EVP & Chief Technology Officer
05/09/24 [Form 4]
Miller Derek
SVP, Human Resources
05/09/24 [Form 4]
Griffith Peter H.
EVP & CFO
05/09/24 [Form 4]
Gordon Murdo
EVP, Global Commercial Ops
05/09/24 [Form 4]
Bradner James E.
EVP, R&D, & Chief Sci. Officer
05/09/24 [Form 4]
End of AMGN's Analysis
CIK: 318154 CUSIP: 031162100 ISIN: US0311621009 LEI: - UEI: -
Secondary Listings